Cardiac CEST-MRI for tracking stem cell survival and determining the role of CXCL2 by Lina Alon et al.
POSTER PRESENTATION Open Access
Cardiac CEST-MRI for tracking stem cell survival
and determining the role of CXCL2
Lina Alon1,2*, Dara Kraitchman1,3, Michael Schär1, Angel Cortez1,2, Nirbhay N Yadav4,1, Judy Cook1,3,
Peter V Johnston5, Rebecca Krimins1,3, Michael T McMahon4,1, Peter van Zijl1,4, Jeff W Bulte1,2, Assaf A Gilad1,2
From 19th Annual SCMR Scientific Sessions
Los Angeles, CA, USA. 27-30 January 2016
Background
Because of the limited endogenous repair mechanisms
that exist in the heart, exogenous stem cell therapies
offer the potential to provide the building blocks for
repair and/or evoke developmental pathways to recruit
endogenous cells that can prevent adverse remodeling
and promote healing. MR-labeling of stem cells with
iron oxides has been used to track stem cells in the
heart, but cannot distinguish viable stem cells from cells
that have died and released iron oxides. In contradis-
tinction, reporter gene labeling offers the advantage that
the reporter is only produced by viable cells. Recently,
chemical exchange saturation transfer (CEST) MRI has
been performed in the heart (cardioCEST) to endogen-
ously detect fibrosis after myocardial infarction in mice
(Vandsburger, M. et al. Circ Cardiovasc Imaging 8,
(2015)). In this study, we seek to image reporter gene-
labeled mesenchymal stem cells (MSCs) in an in vivo
pig model using cardioCEST MRI.
Methods
Human MSCs (hMSCs) were transfected with the
herpes simplex virus type-1-thymidine kinase (HSV1-tk)
reporter gene driven by the CXCL 12 promoter, which
is expressed by stem cells and has been shown to facili-
tate cardiac recovery after myocardial infarction (Penn,
M.S. et al. Gene Ther 19, 583-87 (2012)). All animal stu-
dies were approved by the ACUC. Prior to administra-
tion, transfected MSCs were incubated for 3 hours in 5-
methyl-5, 6-dihydrothymidine (5-MDHT)(Bar-Shir, A.,
et al. Nat. Protocols 8, 2380-91 (2013)) and then washed.
Under general anesthesia with X-ray fluoroscopic gui-
dance, a steerable guide catheter (Myocath, Bioheart)
was advanced to the left ventricle (LV) via a femoral
approach. Multiple transmyocardial injections of 1.
hMSCs, 2. hMSCs incubated with 5-MDHT, and 3.
transfected hMSCs incubated with 5-MDCT were per-
formed in the LV septum. Using a 3T MRI (Achieva,
Philips), ECG-gated, breath-hold segmented gradient
echo (GRE) images were obtained with the following
parameters: 32 × 28 cm2 FOV; 2 × 2 × 20 mm3 voxel;
23 segments/shot; and triggered at end-systole every
third heartbeat in the long axis plane. Five sinc-gaussian
shaped frequency selective 22000 pulses were applied
before data acquisition. Fifty-one different frequencies
were saturated from -833 Hz to 833 Hz in steps of 33
Hz to obtain cardioCEST MRIs. CardioCEST MRs were
displayed as pseudocolor images for interpretation.
Results
Average breath-hold time for cardioCEST images was 20
seconds. Representative cardioCEST MRIs are shown in
Figure 1. The MSC injection sites were not visible on
cine MRIs. cardioCEST MRI was able to distinguish
HSV1-tk hMSCs incubated with the reporter probe vs
control MSCs.
Conclusions
These findings indicate the feasibility of imaging gene
expression with HSV1-tk and detecting the reporter
probe in the heart at clinical field strengths to overcome
some of the issues with direct cell labeling techniques.
Moreover, the specific absorption rate (SAR) that was
used to generate these images was well within clinically
allowed limits.
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Figure 1 a| An anatomical MR image of the heart showing the right ventricle, left ventricle, and the interventricular septum where
the stem cells were transplanted: MSCs expressing HSV1-TK (A) and wild type MSCs (B) were incubated for four hours with 5-MDHT
prior to transplantation and control wild type MSCs (C). b| CEST map overlaid on the anatomical image showing labeled MSCHSV1-TK
appearing as a hot spot (A).
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